Longitudinal prediction of outcome in idiopathic pulmonary fibrosis using automated CT analysis.

Autor: Jacob J; Dept of Respiratory Medicine, University College London, London, UK.; Centre for Medical Image Computing, University College London, London, UK., Bartholmai BJ; Dept of Radiology, Mayo Clinic Rochester, Rochester, MN, USA., van Moorsel CHM; St Antonius ILD Center of Excellence, Dept of Pulmonology, St. Antonius Hospital, Nieuwegein, The Netherlands.; Division of Heart and Lungs, University Medical Center Utrecht, Utrecht, The Netherlands., Rajagopalan S; Dept of Radiology, Mayo Clinic Rochester, Rochester, MN, USA., Devaraj A; Dept of Radiology, Royal Brompton Hospital, London, UK., van Es HW; Dept of Radiology, St. Antonius Hospital, Nieuwegein, The Netherlands., Moua T; Dept of Pulmonary Medicine, Mayo Clinic Rochester, Rochester, MN, USA., van Beek FT; St Antonius ILD Center of Excellence, Dept of Pulmonology, St. Antonius Hospital, Nieuwegein, The Netherlands., Clay R; Dept of Pulmonary Medicine, Mayo Clinic Rochester, Rochester, MN, USA., Veltkamp M; St Antonius ILD Center of Excellence, Dept of Pulmonology, St. Antonius Hospital, Nieuwegein, The Netherlands.; Division of Heart and Lungs, University Medical Center Utrecht, Utrecht, The Netherlands., Kokosi M; Interstitial Lung Disease Unit, Royal Brompton Hospital, Royal Brompton and Harefield NHS Foundation Trust, London, UK., de Lauretis A; Division of Pneumology, 'Guido Salvini' Hospital, Garbagnate Milanese, Italy., Judge EP; Dept of Respiratory Medicine, Aintree University Hospital, Liverpool, UK., Jacob TM; Dept of Radiology, St Georges Hospital, London, UK j.jacob@ucl.ac.uk., Peikert T; Dept of Pulmonary Medicine, Mayo Clinic Rochester, Rochester, MN, USA., Karwoski R; Dept of Physiology and Biomedical Engineering, Mayo Clinic Rochester, Rochester, MN, USA., Maldonado F; Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN, USA., Renzoni E; Interstitial Lung Disease Unit, Royal Brompton Hospital, Royal Brompton and Harefield NHS Foundation Trust, London, UK., Maher TM; NIHR Respiratory Clinical Research Facility, Royal Brompton Hospital, London, UK.; Fibrosis Research Group, National Heart and Lung Institute, Imperial College, London, UK., Altmann A; Centre for Medical Image Computing, University College London, London, UK., Wells AU; Interstitial Lung Disease Unit, Royal Brompton Hospital, Royal Brompton and Harefield NHS Foundation Trust, London, UK.
Jazyk: angličtina
Zdroj: The European respiratory journal [Eur Respir J] 2019 Sep 30; Vol. 54 (3). Date of Electronic Publication: 2019 Sep 30 (Print Publication: 2019).
DOI: 10.1183/13993003.02341-2018
Abstrakt: Competing Interests: Conflict of interest: J. Jacob reports personal fees for advisory board work from Boehringer Ingelheim, outside the submitted work. Conflict of interest: B.J. Bartholmai reports grants (paid to Mayo Clinic) from Royal Brompton Hospital, personal fees from Promedior and Boehringer Ingelheim, during the conduct of the study; royalties (paid to Mayo Clinic) from Imbio, LLC, outside the submitted work; and has a patent Systems and Methods for Analysing in vivo Tissue Volumes using Medical Imaging Data licensed to Imbio LLC. Conflict of interest: C.H.M. van Moorsel has nothing to disclose. Conflict of interest: S. Rajagopalan reports grants (paid to Mayo Clinic) from Royal Brompton Hospital, during the conduct of the study; royalties (paid to Mayo Clinic) from Imbio, LLC, outside the submitted work; and has a patent Systems and Methods for Analysing in vivo Tissue Volumes using Medical Imaging Data licensed to Imbio LLC. Conflict of interest: A. Devaraj reports personal fees from Boehringer Ingelheim and Roche, outside the submitted work. Conflict of interest: H.W. van Es has nothing to disclose. Conflict of interest: T. Moua has nothing to disclose. Conflict of interest: F.T. van Beek has nothing to disclose. Conflict of interest: R. Clay has nothing to disclose. Conflict of interest: M. Veltkamp has nothing to disclose. Conflict of interest: M. Kokosi has nothing to disclose. Conflict of interest: A. de Lauretis has nothing to disclose. Conflict of interest: E.P. Judge has nothing to disclose. Conflict of interest: T.M. Jacob has nothing to disclose. Conflict of interest: T. Peikert has nothing to disclose. Conflict of interest: R. Karwoski reports grants (paid to Mayo Clinic) from Royal Brompton Hospital, during the conduct of the study; royalties (paid to Mayo Clinic) from Imbio, LLC, outside the submitted work; and has a patent Systems and Methods for Analysing in vivo Tissue Volumes using Medical Imaging Data licensed to Imbio LLC. Conflict of interest: F. Maldonado has nothing to disclose. Conflict of interest: E. Renzoni reports personal fees for lectures from Roche and Takeda, personal fees for lectures and advisory board meetings from Boehringher, outside the submitted work. Conflict of interest: T.M. Maher is an investigator in an ongoing Phase 2b study for Gilead; reports grants and personal fees for advisory board work from GSK, grants from Novartis, personal fees from Boehringer Ingelheim InterMune, Lanthio, Sanofi Aventis, AstraZeneca, Roche, Bayer, Biogen Idec, Cipla, Prometic and Apellis, grants, personal fees and research fees (paid to institution) from UCB, outside the submitted work. Conflict of interest: A. Altmann has nothing to disclose. Conflict of interest: A.U. Wells reports personal fees for lectures and advisory board work from Intermune, Boehringer Ingelheim, Roche and Bayer, personal fees for advisory board work from Gilead and MSD, personal fees for lectures from Chiesi, outside the submitted work.
Databáze: MEDLINE